Raj Jena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Raj Jena has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Neil Gunn Burnet
Proton Centre, The Christie NHS Foundation Trust, Manchester, UK
11 shared publications Amanda Johnston
9 shared publicationsBor-Wen Wu
9 shared publicationsFiona P. Harris
9 shared publicationsJane Evanson
9 shared publicationsJim A. Thomson
9 shared publications
Latest Publications
- Open Access
- 18 January 2026
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 8 (1) , tzag006
Assessing current and future demand for PET-CT imaging in England: a comparative analysis of 2013 and 2022 Royal College of Radiologists Guidelines
Objectives: This study aimed to provide a comprehensive analysis of the increasing demand for PET-CT imaging in England, driven by advancements in technology and updated clinical guidelines. By comparing the 2013 and 2022 guidelines issued by the Royal College of Radiologists, the analysis sought to quantify the gap between actual PET-CT provision and modeled requirements, benchmarked against international comparators, to inform strategic planning for equitable access to advanced imaging. Methods: A detailed modeling approach was developed, mapping guideline-based PET-CT scan requirements to disease incidence and stage for major oncological indications (prostate, lymphoma, neuroendocrine tumors, lung, breast, gynecological cancers) and key non-oncological conditions (dementia, cardiovascular disease). Actual scan volumes were extracted from the NHS Diagnostic Imaging Dataset and cross-referenced with provider data. Unmodeled indications were estimated using proportional scaling. Model outputs were validated against PET-CT utilization rates in Finland, adjusted for UK disease incidence. Future demand projections incorporated population growth, demographic shifts, and evolving disease prevalence. Results: For 2021, modeled estimates indicated a substantial shortfall in PET-CT provision for several high-impact indications, notably prostate cancer, dementia, neuroendocrine tumors, and breast cancer, where actual scan volumes were 2-7 times lower than modeled need. Modeled demand for England (361 900 scans/year) exceeded actual provision (239 367 scans/year) by over 50%. Comparative analysis with Finland confirmed that England’s PET-CT rates lagged for most indications except lung cancer. Projections suggest continued growth in demand, particularly for dementia and neuroendocrine tumors, with overall PET-CT needs expected to rise sharply by 2040. Conclusions: England’s current PET-CT capacity falls significantly short of evidence-based requirements, especially for emerging indications in neurology and oncology. Without strategic investment and expansion, this gap will widen, risking delayed diagnosis and suboptimal care. Enhanced data collection and ongoing validation are critical for responsive service planning. Advances in knowledge: This is the first study to comprehensively model PET-CT demand in England across multiple disease categories using updated clinical guidelines and international benchmarking. It provides a robust, data-driven framework for forecasting imaging needs, supporting national policy and equitable resource allocation.
- 18 January 2026
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 8 (1) , tzag006
Open AccessAssessing current and future demand for PET-CT imaging in England: a comparative analysis of 2013 and 2022 Royal College of Radiologists Guidelines
Objectives: This study aimed to provide a comprehensive analysis of the increasing demand for PET-CT imaging in England, driven by advancements in technology and updated clinical guidelines. By comparing the 2013 and 2022 guidelines issued by the Royal College of Radiologists, the analysis sought to quantify the gap between actual PET-CT provision and modeled requirements, benchmarked against international comparators, to inform strategic planning for equitable access to advanced imaging. Methods: A detailed modeling approach was developed, mapping guideline-based PET-CT scan requirements to disease incidence and stage for major oncological indications (prostate, lymphoma, neuroendocrine tumors, lung, breast, gynecological cancers) and key non-oncological conditions (dementia, cardiovascular disease). Actual scan volumes were extracted from the NHS Diagnostic Imaging Dataset and cross-referenced with provider data. Unmodeled indications were estimated using proportional scaling. Model outputs were validated against PET-CT utilization rates in Finland, adjusted for UK disease incidence. Future demand projections incorporated population growth, demographic shifts, and evolving disease prevalence. Results: For 2021, modeled estimates indicated a substantial shortfall in PET-CT provision for several high-impact indications, notably prostate cancer, dementia, neuroendocrine tumors, and breast cancer, where actual scan volumes were 2-7 times lower than modeled need. Modeled demand for England (361 900 scans/year) exceeded actual provision (239 367 scans/year) by over 50%. Comparative analysis with Finland confirmed that England’s PET-CT rates lagged for most indications except lung cancer. Projections suggest continued growth in demand, particularly for dementia and neuroendocrine tumors, with overall PET-CT needs expected to rise sharply by 2040. Conclusions: England’s current PET-CT capacity falls significantly short of evidence-based requirements, especially for emerging indications in neurology and oncology. Without strategic investment and expansion, this gap will widen, risking delayed diagnosis and suboptimal care. Enhanced data collection and ongoing validation are critical for responsive service planning. Advances in knowledge: This is the first study to comprehensively model PET-CT demand in England across multiple disease categories using updated clinical guidelines and international benchmarking. It provides a robust, data-driven framework for forecasting imaging needs, supporting national policy and equitable resource allocation.
- Open Access
- 9 October 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 36, 100850
Identifying the optimal time point for adaptive re-planning in prostate cancer radiotherapy to minimise rectal toxicity using normal tissue imaging biomarkers
- 9 October 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 36, 100850
Open AccessIdentifying the optimal time point for adaptive re-planning in prostate cancer radiotherapy to minimise rectal toxicity using normal tissue imaging biomarkers
- Open Access
- 13 September 2025
- Published by Springer Nature in Neural Computing and Applications
- Vol. 37 (31) , 26021-26036
Balancing misclassification errors in image-based inference using problem domain semantics and a nested cascade architecture
Pattern recognition models, particularly neural networks, often focus on maximising classification accuracy. However, in practice, the types of errors made (misclassification between different classes) can have varying associated costs. Current methods overlook varying misclassification error types. Misclassification labels can either be available from expert knowledge or derived from semantics of textual descriptions of class labels. Exploiting such misclassification costs can have significant implications when deploying machine learning systems. Here, using five examples from image and tabular domains, we show how a deep neural architecture trained in a nested layer-wise fashion (cascade learning) in which early layers solve easier problems than later ones could exploit such hierarchical aspects of class labels. We employ a measure of performance called “severity” of errors and show how emphasis could be placed on classes that are deeper in the hierarchy, ignoring errors that arise between semantic neighbours.
- 13 September 2025
- Published by Springer Nature in Neural Computing and Applications
- Vol. 37 (31) , 26021-26036
Open AccessBalancing misclassification errors in image-based inference using problem domain semantics and a nested cascade architecture
Pattern recognition models, particularly neural networks, often focus on maximising classification accuracy. However, in practice, the types of errors made (misclassification between different classes) can have varying associated costs. Current methods overlook varying misclassification error types. Misclassification labels can either be available from expert knowledge or derived from semantics of textual descriptions of class labels. Exploiting such misclassification costs can have significant implications when deploying machine learning systems. Here, using five examples from image and tabular domains, we show how a deep neural architecture trained in a nested layer-wise fashion (cascade learning) in which early layers solve easier problems than later ones could exploit such hierarchical aspects of class labels. We employ a measure of performance called “severity” of errors and show how emphasis could be placed on classes that are deeper in the hierarchy, ignoring errors that arise between semantic neighbours.
- Open Access
Revolutionizing Brain Tumor Imaging: Generating Synthetic 3D FA Maps from T1-Weighted MRI using CycleGAN Models
Fractional anisotropy (FA) and directionally encoded colour (DEC) maps are essential for evaluating white matter integrity and structural connectivity in neuroimaging. However, the spatial misalignment between FA maps and tractography atlases hinders their effective integration into predictive models. To address this issue, we propose a CycleGAN based approach for generating FA maps directly from T1-weighted MRI scans, representing the first application of this technique to both healthy and tumour-affected tissues. Our model, trained on unpaired data, produces high fidelity maps, which have been rigorously evaluated using Structural Similarity Index (SSIM) and Peak Signal-to-Noise Ratio (PSNR), demonstrating particularly robust performance in tumour regions. Radiological assessments further underscore the model's potential to enhance clinical workflows by providing an AI-driven alternative that reduces the necessity for additional scans.
Open AccessRevolutionizing Brain Tumor Imaging: Generating Synthetic 3D FA Maps from T1-Weighted MRI using CycleGAN Models
Fractional anisotropy (FA) and directionally encoded colour (DEC) maps are essential for evaluating white matter integrity and structural connectivity in neuroimaging. However, the spatial misalignment between FA maps and tractography atlases hinders their effective integration into predictive models. To address this issue, we propose a CycleGAN based approach for generating FA maps directly from T1-weighted MRI scans, representing the first application of this technique to both healthy and tumour-affected tissues. Our model, trained on unpaired data, produces high fidelity maps, which have been rigorously evaluated using Structural Similarity Index (SSIM) and Peak Signal-to-Noise Ratio (PSNR), demonstrating particularly robust performance in tumour regions. Radiological assessments further underscore the model's potential to enhance clinical workflows by providing an AI-driven alternative that reduces the necessity for additional scans.
- 29 March 2025
- Published by Springer Nature
- p. 53-65
Central Nervous System: Essential Neuroanatomy
- 18 October 2024
- Published by Elsevier in Clinical Oncology
- Vol. 37, 103660
OSAIRIS: Lessons Learned From the Hospital-Based Implementation and Evaluation of an Open-Source Deep-Learning Model for Radiotherapy Image Segmentation
- 18 October 2024
- Published by Elsevier in Clinical Oncology
- Vol. 37, 103660
OSAIRIS: Lessons Learned From the Hospital-Based Implementation and Evaluation of an Open-Source Deep-Learning Model for Radiotherapy Image Segmentation
- Open Access
- 19 September 2024
- Published by Elsevier in Future Healthcare Journal
- Vol. 11 (3) , 100165
Democratising artificial intelligence in healthcare: community-driven approaches for ethical solutions
- 19 September 2024
- Published by Elsevier in Future Healthcare Journal
- Vol. 11 (3) , 100165
Open AccessDemocratising artificial intelligence in healthcare: community-driven approaches for ethical solutions
- Open Access
- 3 September 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (10) , e14132
Simulation as a tool to model potential workflow enhancements in radiotherapy treatment pathways – A systematic review
This systematic review aimed to synthesize and summarize the use of simulation of radiotherapy pathways. The objective was to establish the suitability of those simulations in modeling the potential introduction of processes and technologies to speed up radiotherapy pathways. A systematic literature search was carried out using PubMed and Scopus databases to evaluate the use of simulation in radiotherapy pathways. Full journal articles and conference proceedings were considered, and the search was limited to the English language only. To be eligible for inclusion, articles had to model multiple sequential processes in the radiotherapy pathway concurrently to demonstrate the suitability of simulation modeling in typical pathways. Papers solely modeling scheduling, capacity, or queuing strategies were excluded. In total, 151 potential studies were identified and screened to find 18 relevant studies in October 2022. Studies showed that various pathways could be modeled, including the entire pathway from referral to end of treatment or the constituent phases such as pre‐treatment, treatment, or other subcomponents. The data required to generate models varied from study to study, but at least 3 months of data were needed. This review demonstrates that modeling and simulation of radiotherapy pathways are feasible and that model output matches real‐world systems. Validated models give researchers confidence to modify models with potential workflow enhancements to assess their potential effect on real‐world systems. It is recommended that researchers follow best practice guidelines when building models to ensure that they are fit for purpose and to enable decision makers to have confidence in their results.
- 3 September 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (10) , e14132
Open AccessSimulation as a tool to model potential workflow enhancements in radiotherapy treatment pathways – A systematic review
This systematic review aimed to synthesize and summarize the use of simulation of radiotherapy pathways. The objective was to establish the suitability of those simulations in modeling the potential introduction of processes and technologies to speed up radiotherapy pathways. A systematic literature search was carried out using PubMed and Scopus databases to evaluate the use of simulation in radiotherapy pathways. Full journal articles and conference proceedings were considered, and the search was limited to the English language only. To be eligible for inclusion, articles had to model multiple sequential processes in the radiotherapy pathway concurrently to demonstrate the suitability of simulation modeling in typical pathways. Papers solely modeling scheduling, capacity, or queuing strategies were excluded. In total, 151 potential studies were identified and screened to find 18 relevant studies in October 2022. Studies showed that various pathways could be modeled, including the entire pathway from referral to end of treatment or the constituent phases such as pre‐treatment, treatment, or other subcomponents. The data required to generate models varied from study to study, but at least 3 months of data were needed. This review demonstrates that modeling and simulation of radiotherapy pathways are feasible and that model output matches real‐world systems. Validated models give researchers confidence to modify models with potential workflow enhancements to assess their potential effect on real‐world systems. It is recommended that researchers follow best practice guidelines when building models to ensure that they are fit for purpose and to enable decision makers to have confidence in their results.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma
Kaplan Meier plots for PFS and OS
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma
Kaplan Meier plots for PFS and OS
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma
Effects of ADI-PEG20 on the folate pathway
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma
Effects of ADI-PEG20 on the folate pathway